Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, together with theNational Emerging Infectious Diseases Laboratories (NEIDL)1 at Boston University in the US haveconducted research that validates the effectiveness of Signify’s UV-C light sources on the inactivation ofSARS-CoV-2, the virus that causes COVID-19.Since the start of the SARS CoV-2 pandemic, Dr. Anthony Griffiths, Associate Professor of Microbiology atBoston University School of Medicine and his team have been working on developing tools to supportscientific advancement in this field.2 During their research they have treated inoculated material withdifferent doses of UV-C radiation coming from a Signify light source and assessed the inactivationcapacity under various conditions. The team applied a dose of 5mJ/cm2, resulting in a reduction of theSARS-CoV-2 virus of 99% in 6 seconds. Based on the data, it was determined that a dose of 22mJ/cm2 willresult in a reduction of 99.9999% in 25 seconds.